Microdosing may also result in unpredictable side effects
Vague Labeling: Avoid products that do not clearly specify the exact peptide content, molecular weight, or Research Only status
While this has not been observed in humans, it remains a theoretical risk, and patients with a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) are typically advised against using Semaglutide
Treatment starts at a low dose and is gradually increased to improve tolerability
It regulates over 4000 human genes, with the end result being a potential improvement in skin health which can support a more youthful look
27, 30, or higher BMI, this number gives you a baseline and helps determine if you meet the typical GLP-1 requirements